BCL2L1 Protein — BCL-XL

BCL2L1 Protein — BCL-XL

Introduction

Pathway Diagram

```mermaid
flowchart TD
FOXO["FOXO<br/>Transcription Factor"] -->|"activates"| BCL2L1["BCL2L1<br/>(Bcl-xL)<br/>Anti-apoptotic Protein"]

BCL2L1 -->|"inhibits"| Apoptosis["Cellular Apoptosis<br/>Programmed Cell Death"]
BCL2L1 -->|"regulates"| Mitochondria["Mitochondrial<br/>Membrane Stability"]

Apoptosis -->|"leads to"| Neurodegeneration["Neurodegeneration<br/>Neural Cell Loss"]
Mitochondria -->|"dysfunction causes"| Neurodegeneration

BCL2L1 -->|"regulates"| Alzheimer["Alzheimer's Disease<br/>Cognitive Decline"]
BCL2L1 -->|"inhibits"| ALS["Amyotrophic Lateral<br/>Sclerosis (ALS)"]
BCL2L1 -->|"associated with"| Parkinson["Parkinson's Disease<br/>Motor Dysfunction"]
BCL2L1 -->|"associated with"| MS["Multiple Sclerosis<br/>Demyelination"]

BCL2L1 -->|"regulates"| Inflammation["Neuroinflammation<br/>Immune Response"]
BCL2L1 -->|"regulates"| Aging["Cellular Aging<br/>Senescence"]
BCL2L1 -->|"associated with"| Ischemia["Cerebral Ischemia<br/>Oxygen Deprivation"]

Inflammation -->|"contributes to"| Neurodegeneration
Aging -->|"promotes"| Neurodegeneration
Ischemia -->|"triggers"| Apoptosis

BCL2L1 -->|"biomarker for"| Senescence["Cellular Senescence<br/>Age-related Decline"]

style BCL2L1 fill:#006494
style FOXO fill:#4a1a6b
style Apoptosis fill:#ef5350
style Neurodegeneration fill:#5d4400
style Mitochondria fill:#1b5e20
style Inflammation fill:#ef5350
style Aging fill:#5d4400
style Senescence f

BCL2L1 Protein — BCL-XL

Introduction

Pathway Diagram

Bcl2L1 Protein — Bcl Xl is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

<div class="infobox infobox-protein">
<h3>BCL2L1 Protein</h3>
<table>
<tr><th>Protein Name</th><td>BCL-XL (B-Cell Lymphoma-Extra Large)</td></tr>
<tr><th>Gene</th><td>[BCL2L1](/genes/bcl2l1)</td></tr>
<tr><th>UniProt ID</th><td>[Q07817](https://www.uniprot.org/uniprot/Q07817)</td></tr>
<tr><th>Protein Size</th><td>233 amino acids (~30 kDa); alternative splicing generates BCL-XS (178 aa)</td></tr>
<tr><th>Subcellular Localization</th><td>Mitochondrial outer membrane; endoplasmic reticulum; nucleus</td></tr>
<tr><th>Protein Family</th><td>BCL-2 family (anti-apoptotic)</td></tr>
<tr><th>PDB Structures</th><td>[1LXL](https://www.ebi.ac.uk/pdbe/search/pdb/1LXL), [1R2D](https://www.ebi.ac.uk/pdbe/search/pdb/1R2D), [5AGW](https://www.ebi.ac.uk/pdbe/search/pdb/5AGW)</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/autoimmune" style="color:#ef9a9a">Autoimmune</a></td>
</tr>
<tr>
<td class="label">SciDEX Hypotheses</td>
<td><a href="/hypothesis/h-3f02f222" style="color:#ce93d8" title="Score: 0.52">Senescent Microglia Resolution via Mares...</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">358 edges</a></td>
</tr>
</table>
</div>

BCL-XL (BCL2L1) is a critical anti-apoptotic protein of the BCL-2 family that inhibits mitochondrial [apoptosis](/entities/apoptosis) by preventing mitochondrial outer membrane permeabilization (MOMP). It is a key regulator of neuronal survival and is implicated in various neurodegenerative diseases.

Structure

BCL-XL has the characteristic BCL-2 family fold:

• BH4 Domain (aa 1-24): Required for anti-apoptotic function
• BH3 Domain (aa 82-93): Critical for interaction with pro-apoptotic proteins
• BH1 Domain (aa 136-149): Forms part of the BH3-binding pocket
• BH2 Domain (aa 177-189): Contributes to oligomerization and function
• Transmembrane Domain (aa 210-230): Anchors protein to membranes

Alternative Splicing: BCL2L1 produces two major isoforms:

• BCL-XL (233 aa): Anti-apoptotic, inhibits apoptosis
• BCL-XS (178 aa): Pro-apoptotic, promotes cell death

Normal Function

BCL-XL performs essential anti-apoptotic functions:

Role in Disease

Alzheimer's Disease

• [Neurons](/entities/neurons) in AD show increased BCL-XL as a compensatory neuroprotective response
• However, BCL-XL function becomes impaired by interaction with other disease proteins
• [Tau](/proteins/tau) pathology affects BCL-XL localization and function

Parkinson's Disease

• BCL-XL protects dopaminergic neurons from various toxic insults
• Reduced BCL-XL in PD substantia nigra contributes to vulnerability
• MPTP and other PD toxins downregulate BCL-XL

Amyotrophic Lateral Sclerosis (ALS)

• Mutant SOD1 directly interacts with BCL-XL, impairing its anti-apoptotic function
• BCL-XL levels correlate with motor neuron survival
• Targeting BCL-XL is being explored therapeutically

Stroke and Brain Injury

• BCL-XL is neuroprotective in ischemic injury models
• Overexpression reduces infarct size in experimental stroke

Cancer

• BCL-XL is frequently overexpressed in cancers (especially BCL-XL vs BCL-2)
• Major resistance factor against chemotherapy
• Target of BH3 mimetic drugs (e.g., Navitoclax)

Therapeutic Targeting

BCL-XL is a major therapeutic target:

• BH3 Mimetics: Navitoclax (ABT-263), Venetoclax (ABT-199 - more BCL-2 selective), DT2216
• Direct Inhibitors: Small molecules that neutralize BCL-XL anti-apoptotic function
• Protein-Protein Interaction Blockers: Prevent BCL-XL from binding pro-apoptotic proteins

Interactions

BCL-XL interacts with:

• BAX: Inhibits pro-apoptotic oligomerization
• BAK: Prevents activation
• BH3-only proteins: BIM, BAD, BID, PUMA, NOXA (sequesters them)
• BECN1: Inhibits autophagy
• Mutant SOD1: In ALS, binds and sequesters BCL-XL
• VDAC: Modulates mitochondrial permeability

See Also

• [BCL2L1 Gene](/genes/bcl2l1)
• [BCL2 Family in Apoptosis](/mechanisms/bcl2-family-apoptosis)
• [Mitochondrial Apoptosis Pathway](/mechanisms/apoptosis-pathways)
• [Mitochondrial Dysfunction in Neurodegeneration](/mechanisms/mitochondrial-dysfunction)
• [BH3 Mimetics in Neurodegeneration](/therapeutics/bh3-mimetics)

Background

The study of Bcl2L1 Protein — Bcl Xl has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

• [PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
• [Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
• [Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data

References

PMID: 8612244(https://pubmed.ncbi.nlm.nih.gov/8612244/)